Journal
JOURNAL OF PHARMACY AND PHARMACOLOGY
Volume 62, Issue 12, Pages 1740-1745Publisher
WILEY
DOI: 10.1111/j.2042-7158.2010.01164.x
Keywords
aldosterone; amlodipine; cardiac gene expression; fibronectin; SHR-SP
Categories
Ask authors/readers for more resources
Objectives Amlodipine, a calcium channel blocker (CCB), is one of the most common antihypertensive medicines in Japan. We evaluated whether the calcium channel blocker confers cardiac protection through the renin-angiotensin-aldosterone system in male stroke-prone spontaneously hypertensive rats (SHR-SP). Methods Fifteen week-old rats were divided into 2 groups: amlodipine group (3 mg/kg/day, n = 5) and control group (n = 5). Key findings The CCB lowered systolic blood pressure significantly (P < 0.05). Plasma aldosterone concentration in the amlodipine group was remarkably lower than in the control group (P < 0.05), but plasma renin activity and plasma angiotensin II concentration were not different between the two groups. The CCB also suppressed the mRNA expression of brain natriuretic peptide, transforminggrowth factor-beta(1), and fibronectin extracted from the left ventricle. Conclusions These results suggest that amlodipine attenuates cardiac damage by lowering plasma aldosterone concentration in hypertensive rats with developing arteriosclerosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available